Compare
Merck & vs Phibro Animal Health (MRK vs PAHC)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Merck & (MRK) returned +73.9% and Phibro Animal Health (PAHC) -19.9%; so far this year the figures are +39.4% and -11.8%.
Merck & is the larger company by market value, about 267.9 times the size of Phibro Animal Health.
On trailing earnings, MRK trades at 149.7 times and PAHC at 13.1 times.
Revenue grew +4.9% at MRK and +10.1% at PAHC over the last year.
MRK yields 2.32%. PAHC yields 1.46%.
Data as of the latest close. Not investment advice.
Relative performance
| MRK | PAHC | |
|---|---|---|
| Price | $146.73 | $32.96 |
| 1-day | -0.14% | -6.89% |
| YTD | +39.40% | -11.78% |
| 1 year | +73.87% | -19.90% |
| 3 years | +42.66% | +194.55% |
| Market cap | $361.7B | $1.4B |
| P/E | 149.7 | 13.1 |
| P/S | 5.37 | 0.88 |
| P/B | 8.06 | 3.23 |
| Revenue growth | +4.90% | +10.10% |
| EPS growth | -87.10% | +50.30% |
| Gross margin % | 71.8 | 33.8 |
| Net margin % | 3.6 | 6.7 |
| ROE % | 5.5 | 24.6 |
| Debt / equity | 1.20 | 1.46 |
| FCF yield % | 4.1 | 1.6 |
| Dividend yield % | 2.32 | 1.46 |
| Beta | 0.18 | 0.92 |
| RSI (14) | 51.3 | 33.0 |
| Technical rating |